4Q Sales Results

Discussion in 'Collegium Pharmaceutical' started by anonymous, Mar 23, 2017 at 10:48 AM.

Tags: Add Tags
  1. #1 anonymous, Mar 23, 2017 at 10:48 AM
    anonymous

    anonymous Guest

    Net product revenues for Xtampza ER were $1.3 million for the 2016 Quarter compared to none for the 2015 Quarter. Net product revenues increased by 219% for the 2016 Quarter compared to the quarter ended September 30, 2016.
     
    Quote

  2. #2 anonymous, Mar 24, 2017 at 11:51 AM
    anonymous

    anonymous Guest

    Growing nicely!
     
    Quote
Reply to Thread